• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
MUCIN 1 ONCOPROTEIN EXPRESSION IS SUPPRESSED BY THE miR-125b ONCOMIR.miR-125b致癌miRNA抑制黏蛋白1癌蛋白的表达。
Genes Cancer. 2010 Jan 1;1(1):62-68. doi: 10.1177/1947601909357933.
2
Androgen receptor regulates expression of the MUC1-C oncoprotein in human prostate cancer cells.雄激素受体调节人前列腺癌细胞中 MUC1-C 癌蛋白的表达。
Prostate. 2011 Sep;71(12):1299-308. doi: 10.1002/pros.21344. Epub 2011 Feb 9.
3
miR-1226 targets expression of the mucin 1 oncoprotein and induces cell death.miR-1226 靶向黏蛋白 1 癌蛋白的表达并诱导细胞死亡。
Int J Oncol. 2010 Jul;37(1):61-9. doi: 10.3892/ijo_00000653.
4
The HIV-1 capsid-binding host factor CPSF6 is post-transcriptionally regulated by the cellular microRNA miR-125b.HIV-1 衣壳结合宿主因子 CPSF6 受细胞 microRNA miR-125b 的转录后调控。
J Biol Chem. 2020 Apr 10;295(15):5081-5094. doi: 10.1074/jbc.RA119.010534. Epub 2020 Mar 9.
5
Interplay between RNA-binding protein HuR and microRNA-125b regulates p53 mRNA translation in response to genotoxic stress.RNA结合蛋白HuR与微小RNA-125b之间的相互作用调节p53 mRNA翻译以响应基因毒性应激。
RNA Biol. 2016 Nov;13(11):1152-1165. doi: 10.1080/15476286.2016.1229734. Epub 2016 Sep 3.
6
LncRNA SNHG6/miR-125b-5p/BMPR1B Axis: A New Therapeutic Target for Triple-Negative Breast Cancer.长链非编码RNA SNHG6/微小RNA-125b-5p/骨形态发生蛋白受体1B轴:三阴性乳腺癌的新治疗靶点
Front Oncol. 2021 May 7;11:678474. doi: 10.3389/fonc.2021.678474. eCollection 2021.
7
Poly (ADP-Ribose) Polymerase-1 (PARP-1) Induction by Cocaine Is Post-Transcriptionally Regulated by miR-125b.可卡因诱导的多聚(ADP-核糖)聚合酶 1(PARP-1)表达受 miR-125b 的转录后调控。
eNeuro. 2017 Aug 18;4(4). doi: 10.1523/ENEURO.0089-17.2017. eCollection 2017 Jul-Aug.
8
Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer.抑癌 miR-125b 通过调控 p14(ARF) 抑制前列腺癌细胞凋亡。
PLoS One. 2013 Apr 9;8(4):e61064. doi: 10.1371/journal.pone.0061064. Print 2013.
9
miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer.miR-125b 通过调控人类浸润性乳腺癌中的 ETS1 原癌基因而被甲基化,并发挥肿瘤抑制作用。
Cancer Res. 2011 May 15;71(10):3552-62. doi: 10.1158/0008-5472.CAN-10-2435. Epub 2011 Mar 28.
10
MiR-125b attenuates human hepatocellular carcinoma malignancy through targeting SIRT6.微小RNA-125b通过靶向沉默调节蛋白6减轻人肝细胞癌的恶性程度。
Am J Cancer Res. 2018 Jun 1;8(6):993-1007. eCollection 2018.

引用本文的文献

1
Exploring New Frontiers: Alternative Breast Cancer Treatments Through Glycocalyx Research.探索新前沿:通过糖萼研究寻找乳腺癌替代治疗方法
Breast J. 2025 May 22;2025:9952727. doi: 10.1155/tbj/9952727. eCollection 2025.
2
Role of microRNAs in triple‑negative breast cancer and new therapeutic concepts (Review).微小RNA在三阴性乳腺癌中的作用及新治疗理念(综述)
Oncol Lett. 2024 Jul 11;28(3):431. doi: 10.3892/ol.2024.14565. eCollection 2024 Sep.
3
miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine.miR-125在乳腺癌病因发病机制中的作用:作为鉴别诊断、再生医学及个性化医学挑战中的生物标志物的新角色
Noncoding RNA. 2024 Feb 21;10(2):16. doi: 10.3390/ncrna10020016.
4
The Tumorigenicity of Breast Cancer Cells Is Reduced upon Treatment with Small Extracellular Vesicles Isolated from Heparin Treated Cell Cultures.经肝素处理的细胞培养物中分离出的小细胞外囊泡处理后,乳腺癌细胞的致瘤性降低。
Int J Mol Sci. 2023 Oct 29;24(21):15736. doi: 10.3390/ijms242115736.
5
Autoantibodies as biomarkers for breast cancer diagnosis and prognosis.自身抗体作为乳腺癌诊断和预后的生物标志物。
Front Immunol. 2022 Nov 14;13:1035402. doi: 10.3389/fimmu.2022.1035402. eCollection 2022.
6
Aminoflavone upregulates putative tumor suppressor miR-125b-2-3p to inhibit luminal A breast cancer stem cell-like properties.氨基黄酮上调假定的肿瘤抑制因子miR-125b-2-3p以抑制腔面A型乳腺癌干细胞样特性。
Precis Clin Med. 2022 Mar 28;5(2):pbac008. doi: 10.1093/pcmedi/pbac008. eCollection 2022 Jun.
7
Changes in miR-124-1, miR-212, miR-132, miR-134, and miR-155 Expression Patterns after 7,12-Dimethylbenz(a)anthracene Treatment in CBA/Ca Mice.7,12-二甲基苯并蒽处理后 CBA/Ca 小鼠中 miR-124-1、miR-212、miR-132、miR-134 和 miR-155 表达模式的变化。
Cells. 2022 Mar 17;11(6):1020. doi: 10.3390/cells11061020.
8
Novel insights into the roles and therapeutic implications of MUC1 oncoprotein via regulating proteins and non-coding RNAs in cancer.通过调节癌症中的蛋白质和非编码 RNA 揭示 MUC1 癌蛋白在肿瘤发生中的作用和治疗意义。
Theranostics. 2022 Jan 1;12(3):999-1011. doi: 10.7150/thno.63654. eCollection 2022.
9
MicroRNA-125b inhibits the proliferation of vascular smooth muscle cells induced by platelet-derived growth factor BB.微小RNA-125b抑制血小板衍生生长因子BB诱导的血管平滑肌细胞增殖。
Exp Ther Med. 2021 Aug;22(2):791. doi: 10.3892/etm.2021.10223. Epub 2021 May 24.
10
Tiny miRNAs Play a Big Role in the Treatment of Breast Cancer Metastasis.微小的miRNA在乳腺癌转移治疗中发挥重要作用。
Cancers (Basel). 2021 Jan 18;13(2):337. doi: 10.3390/cancers13020337.

本文引用的文献

1
Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer.黏蛋白1癌蛋白与信号转导和转录激活因子1通路在预后不良的人类乳腺癌中的协同作用。
Oncogene. 2010 Feb 11;29(6):920-9. doi: 10.1038/onc.2009.391. Epub 2009 Nov 16.
2
MUC1 oncoprotein is a druggable target in human prostate cancer cells.MUC1 癌蛋白是人类前列腺癌细胞中的一个可用药靶。
Mol Cancer Ther. 2009 Nov;8(11):3056-65. doi: 10.1158/1535-7163.MCT-09-0646. Epub 2009 Nov 3.
3
MUC1-C oncoprotein functions as a direct activator of the nuclear factor-kappaB p65 transcription factor.黏蛋白1-C癌蛋白作为核因子-κB p65转录因子的直接激活剂发挥作用。
Cancer Res. 2009 Sep 1;69(17):7013-21. doi: 10.1158/0008-5472.CAN-09-0523. Epub 2009 Aug 25.
4
MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets.人类转移性癌症的微小RNA表达谱分析可识别癌症基因靶点。
J Pathol. 2009 Oct;219(2):214-21. doi: 10.1002/path.2586.
5
Functional targeting of the MUC1 oncogene in human cancers.人癌症中MUC1癌基因的功能靶向
Cancer Biol Ther. 2009 Jul;8(13):1197-203. doi: 10.4161/cbt.8.13.8844. Epub 2009 Jul 27.
6
MicroRNA-125b is a novel negative regulator of p53.微小RNA - 125b是一种新型的p53负调控因子。
Genes Dev. 2009 Apr 1;23(7):862-76. doi: 10.1101/gad.1767609. Epub 2009 Mar 17.
7
MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment.MUC1诱导的脂质代谢基因网络改变可预测人类乳腺癌对他莫昔芬治疗的反应。
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5837-41. doi: 10.1073/pnas.0812029106. Epub 2009 Mar 16.
8
MicroRNAs: target recognition and regulatory functions.微小RNA:靶标识别与调控功能
Cell. 2009 Jan 23;136(2):215-33. doi: 10.1016/j.cell.2009.01.002.
9
Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation.miR-125b-1在骨髓增生异常综合征及伴有t(2;11)(p21;q23)易位的急性髓系白血病中导致髓系细胞分化阻滞
J Exp Med. 2008 Oct 27;205(11):2499-506. doi: 10.1084/jem.20080285. Epub 2008 Oct 20.
10
MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation.针对Nanog、Oct4和Sox2编码区域的微小RNA可调节胚胎干细胞分化。
Nature. 2008 Oct 23;455(7216):1124-8. doi: 10.1038/nature07299. Epub 2008 Sep 17.

miR-125b致癌miRNA抑制黏蛋白1癌蛋白的表达。

MUCIN 1 ONCOPROTEIN EXPRESSION IS SUPPRESSED BY THE miR-125b ONCOMIR.

作者信息

Rajabi Hasan, Jin Caining, Ahmad Rehan, McClary Cain, Joshi Maya Datt, Kufe Donald

机构信息

Dana-Farber Cancer Institute Harvard Medical School Boston, MA 02115.

出版信息

Genes Cancer. 2010 Jan 1;1(1):62-68. doi: 10.1177/1947601909357933.

DOI:10.1177/1947601909357933
PMID:20729973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2923812/
Abstract

The MUC1 oncoprotein is overexpressed in most human breast cancers by mechanisms that are incompletely understood. The microRNA, miR-125b, is downregulated in breast cancer cells. The present studies demonstrate that the MUC1 3'UTR contains a site for binding of the miR-125b seed region. The results show that the MUC1 3'UTR suppresses luciferase expression and that this effect is abrogated by mutation or deletion of the miR-125b binding site. Expression of an anti-sense miR-125b in BT-549 breast cancer cells was associated with induction of MUC1 protein, but not MUC1 mRNA, levels. The anti-sense miR-125b also increased BT-549 cell growth by a MUC1-dependent mechanism. In addition, overexpression of exogenous miR-125b downregulated MUC1 protein, and not MUC1 transcripts, in ZR-75-1 breast cancer cells. Silencing of MUC1 in ZR-75-1 cells with a siRNA has been shown to promote DNA damage-induced apoptosis. In concert with these observations, miR-125b-induced decreases in MUC1 levels increased the apoptotic response of ZR-75-1 cells to cisplatin treatment. These findings indicate that miR-125b suppresses translation of the MUC1 oncoprotein and that miR-125b thereby functions as a tumor suppressor in breast cancer cells.

摘要

MUC1癌蛋白在大多数人类乳腺癌中过度表达,但其机制尚未完全明确。微小RNA miR-125b在乳腺癌细胞中表达下调。目前的研究表明,MUC1 3'非翻译区(UTR)含有一个可与miR-125b种子区域结合的位点。结果显示,MUC1 3'UTR可抑制荧光素酶表达,而miR-125b结合位点的突变或缺失可消除这种作用。在BT-549乳腺癌细胞中表达反义miR-125b与MUC1蛋白水平的诱导相关,但与MUC1 mRNA水平无关。反义miR-125b还通过MUC1依赖的机制促进BT-549细胞生长。此外,在ZR-75-1乳腺癌细胞中外源miR-125b的过表达下调了MUC1蛋白水平,而非MUC1转录本水平。已证明用小干扰RNA(siRNA)使ZR-75-1细胞中的MUC1沉默可促进DNA损伤诱导的细胞凋亡。与这些观察结果一致,miR-125b诱导的MUC1水平降低增加了ZR-75-1细胞对顺铂治疗的凋亡反应。这些发现表明,miR-125b抑制MUC1癌蛋白的翻译,因此miR-125b在乳腺癌细胞中发挥肿瘤抑制作用。